A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma

被引：0
|
作者：
Satoshi Murahashi
Daisuke Takahari
Takeru Wakatsuki
Naoki Fukuda
Takashi Ichimura
Mariko Ogura
Masato Ozaka
Eiji Shinozaki
Izuma Nakayama
Tomohiro Matsushima
Hiroki Osumi
Keisho Chin
Kensei Yamaguchi
机构：
[1] The Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Gastroenterology
来源：
International Journal of Clinical Oncology | 2018年 / 23卷
关键词：
Ramucirumab; Monotherapy; Gastric Cancer; Japanese;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：92 / 97
页数：5
相关论文
共 50 条
  • [1] A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma
    Murahashi, Satoshi
    Takahari, Daisuke
    Wakatsuki, Takeru
    Fukuda, Naoki
    Ichimura, Takashi
    Ogura, Mariko
    Ozaka, Masato
    Shinozaki, Eiji
    Nakayama, Izuma
    Matsushima, Tomohiro
    Osumi, Hiroki
    Chin, Keisho
    Yamaguchi, Kensei
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (01) : 92 - 97
  • [2] Ramucirumab for advanced gastric or GEJ adenocarcinoma in previously treated patients with disease progression
    Abraham, Jame
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (12): : 428 - 430
  • [3] A phase 1/2 study of ramucirumab plus nivolumab in patients with previously treated advanced gastric adenocarcinoma
    Shoji, H.
    Miyamoto, H.
    Hara, H.
    Takahari, D.
    Machida, N.
    Esaki, T.
    Nagashima, K.
    Aoki, K.
    Honda, K.
    Nagata, Y.
    Miyamoto, T.
    Boku, N.
    Kato, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [4] Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer
    Sadayuki Kawai
    Naoki Fukuda
    Shun Yamamoto
    Seiichiro Mitani
    Katsuhiro Omae
    Takeru Wakatsuki
    Ken Kato
    Shigenori Kadowaki
    Daisuke Takahari
    Narikazu Boku
    Kei Muro
    Nozomu Machida
    BMC Cancer, 20
  • [5] Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer
    Kawai, Sadayuki
    Fukuda, Naoki
    Yamamoto, Shun
    Mitani, Seiichiro
    Omae, Katsuhiro
    Wakatsuki, Takeru
    Kato, Ken
    Kadowaki, Shigenori
    Takahari, Daisuke
    Boku, Narikazu
    Muro, Kei
    Machida, Nozomu
    BMC CANCER, 2020, 20 (01)
  • [6] Indirect comparison of ramucirumab and alternatives in advanced or metastatic gastric adenocarcinoma
    Guerra Estevez, D.
    Campos Davila, E.
    Alegre del Rey, E.
    Villanueva Jimenez, P.
    Marmesat Rodas, B.
    Marquez Fernandez, E.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 584 - 584
  • [7] Ramucirumab monotherapy for advanced gastric cancer
    Yaqub, Farhat
    LANCET ONCOLOGY, 2013, 14 (12): : E495 - E495
  • [8] Previously treated Patients with advanced Gastric Cancer Ramucirumab: Important Expansion in Palliative Therapy
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (05) : 308 - 308
  • [9] Ramucirumab and irinotecan in patients with previously treated gastroesophageal adenocarcinoma.
    Park, Haeseong
    Trikalinos, Nikolaos
    Sanjeevaiah, Aravind
    Pedersen, Katrina
    Bagegni, Nusayba Ali
    Nixon, Andrew B.
    Huffman, Jesse
    Tan, Benjamin R.
    Suresh, Rama
    Lim, Kian-Huat
    Amin, Manik A.
    Wang-Gillam, Andrea
    Lockhart, A. Craig
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Preliminary result of phase 1/2 study of ramucirumab plus nivolumab in patients with previously treated advanced gastric adenocarcinoma (NivoRam study).
    Takahari, Daisuke
    Shoji, Hirokazu
    Hara, Hiroki
    Esaki, Taito
    Machida, Nozomu
    Nagashima, Kengo
    Aoki, Kazunori
    Honda, Kazufumi
    Miyamoto, Takahiro
    Boku, Narikazu
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345